Vivimed W/O Sunscreen Formulation

Vivimed Labs Ltd
Phase
Product
INCI Name
Supplier
Volume
A

Arlacel 1690

Sorbitan Isostearate (and) Polyglyceryl-3 Polyricinoleate

Croda

3.5

Span 83

Sorbitan Sesquioleate

Croda

1.00

Arlamol HD

Isohexadecane

Croda

3.00

Finsolv EB

Ethylhexyl Benzoate

Innospec

10.00

Candelilla Wax

Candelilla Cera

Various

0.50

OMC

Ethylhexyl Methoxycinnamate

Various

4.00

Avis

Butyl Methoxydibenzoylmethane

Vivimed

4.00

Etone

Ethylhexyl Triazone

Vivimed

2.00

Titriplex III

Disodium EDTA

Merck

0.10

RonaCare AP

Bis-ethylhexyl Hydroxydimethoxy Benzylmalonate

Merck

1.00

Tegosoft XC

Phenoxyethyl Caprylate

Evonik

5.00

B

Bentone Gel IHD-V

Isohexadecane (and) Disteardimonium Hectorite (and) Propylene Carbonate

Elementis

3.00

C

Deionised Water

Aqua

48.20

Pricerine 9091

Glycerine

Croda

3.00

MgSO4.7H2O

Magnesium Sulphate Heptahydrate

Various

0.70

Vivsonic

Phenylbenzimidazole Sulfonic Acid

Vivimed

2.00

Triethanolamine 90%

Triethanolamine

Various

1.20

D

Solaveil XT-100

Titanium Dioxide (and) C12-15 Alkyl Benzoate (and) Polyhydroxystearic Acid (and) Stearic Acid (and) Alumina

Croda

7.00

E

Euxyl PE9010

Phenoxyethanol (and) Ethylhexylglycerin

Clariant

0.80

Preparation:

  1.  Combine phase A and heat to 80-85oC.
    
  2.  When fully molten and homogenous, add phase B and homogenise. Re-heat to 75-80oC.
    
  3.  Prepare phase C  and heat to 75-80°C.
    
  4.  Add C to A/B slowly with intensive stirring. Homogenise for 2 mins per 100g.
    
  5.  Add D with stirring. Homogenise for 1 min.
    
  6.  Cool with intensive stirring to 50oC.
    
  7.  Add phase E below 50oC. Continue to cool with stirring to room temp.
    

Notes:

Test Data: 8240cps / in-vitro SPF53 / UVA:UVB ratio 0.746

Disclaimer

While every effort has been made to reproduce these formulations correctly, the Publisher of this website cannot accept any liability for the information presented. All formulations are provided in good faith, but no warranty is given as to accuracy of information or results, or suitability for a particular use, nor is freedom from patent infringement to be inferred. Formulations are offered solely for consideration by the participating manufacturers. Continued use of this web site infers acceptance of this disclaimer.

Latest Issues

NYSCC Suppliers' Day 2026

Javits Center, New York
19 - 20 May

in-cosmetics Korea 2026

COEX, Seoul
1 - 3 July 2026